FB704A

BIOLOGICAL2 trials

Sponsors

Fountain Biopharma Inc., Oneness Biotech Co., Ltd.

Conditions

Rheumatoid ArthritisSevere Asthma

Phase 1

Evaluate the Safety, Tolerability, Pharmacokinetics,and Clinical Activity of FB704A

CompletedNCT03890302

Fountain Biopharma Inc.Rheumatoid Arthritis

Start: 2019-03-14End: 2020-05-27Updated: 2020-07-21

Phase 2

Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma

CompletedNCT05018299

Oneness Biotech Co., Ltd.Severe Asthma

Start: 2021-09-30End: 2026-05-08Updated: 2026-07-09